Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: Historical cohort study

British Medical Journal

Volumn 325, Issue 7374, 2002, Pages 1199-1201

  Zammit, Stanley ^a   Allebeck, Peter ^b   Andreasson, Sven ^c   Lundberg, Ingvar ^c   Lewis, Glyn ^d  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS;

ADULT; ARTICLE; CANNABIS ADDICTION; DISEASE ASSOCIATION; HUMAN; MALE; PERSONALITY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SELF REPORT; SOCIAL ASPECT; SWEDEN;

EID: 0037164374     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Thomas H. Psychiatric symptoms in cannabis users. Br J Psychiatry 1993;163:141-9.
2. Hall W, Solowij N, Lemon J. The Health and Psychological Consequences of Cannabis Use. Canberra: Australian Government Publishing Service, 1994.
3. Johns A. Psychiatric effects of cannabis. Br J Psychiatry 2001;178:116-22.
4. Andreasson S, Allebeck P, Engstrom A, Rydberg U. Cannabis and schizophrenia. A longitudinal study of Swedish conscripts. Lancet 1987;2:1483-6.
5. Johnson BA, Smith BL, Taylor P. Cannabis and schizophrenia. Lancet 1988;1:592-3.
6. Negrete JC. Cannabis and schizophrenia. Br J Addict 1989;84:349-51.
7. Hall W, Degenhardt L. Cannabis use and psychosis: A review of clinical and epidemiological evidence. Aust N Z J Psychiatry 2000;34:26-34.
8. Andreasson S, Allebeck P, Rydberg U. Schizophrenia in users and nonusers of cannabis. A longitudinal study in Stockholm County. Acta Psychiatr Scand 1989;79:505-10.
9. Johnstone EC. Schizophrenia. In: Johnstone EC, Freeman CPL, Zealley AK. Companion to Psychiatric Studies. 6th Ed. London: Churchill Livingstone, 1998:369-97.
10. Lewis G, David A, Andreasson S, Allebeck P. Schizophrenia and city life. Lancet 1992;340:137-40.
11. David AS, Malmberg A, Brandt L, Allebeck P, Lewis G. 1Q and risk for schizophrenia: A population-based cohort study. Psychol Med 1997;27:1311-23.
12. Malmberg A, Lewis G, David A. Allebeck P. Premorbid adjustment and personality in people with schizophrenia. Br J Psychiatry 1998;172:308-13.
13. Lewis G, David AS, Malmberg A, Allebeck P. Non-psychotic psychiatric disorder and subsequent risk of schizophrenia. Cohort study. Br J Psychiatry 2000;177:416-20.
14. Otto U. Function of male youths during military service. A follow-up study of a youth clientele. Acta Psychiatr Scand 1980;282 (suppl):1-60.
15. World Health Organization. Glossary of Mental Disorders and Guide to their Classification for Use in Conjunction with International Classification of Diseases. Eight Revision. Geneva: WHO, 1974.
16. Geddes JR, Kendell RE. Schizophrenic subjects with no history of admission to hospital. Psychol Med 1995;25:859-68.
17. Chen K, Kandel DB. The natural history of drug use from adolescence to the mid-thirties in a general population sample. Am J Public Health 1995;85:41-7.
18. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism. Science 1997;276:2048-50.
19. Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: A review and reconceptualization. Am J Psychiatry 1991;148:1474-86.
20. Singleton N, Bumpstead R, O'Brien M, Lee A, Meltzer H. Psychiatric Morbidity Among Adults Living in Private Households, 2000. London: Stationery Office, 2001.